Afinitor Interactions
There are 547 drugs known to interact with Afinitor (everolimus), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 179 are major, 357 are moderate, and 11 are minor.
- View all 547 medications that may interact with Afinitor
- View Afinitor alcohol/food interactions (2)
- View Afinitor disease interactions (8)
Most frequently checked interactions
View interaction reports for Afinitor (everolimus) and the medicines listed below.
- amlodipine
- Aromasin (exemestane)
- atorvastatin
- Benadryl (diphenhydramine)
- Calcium 600 D (calcium / vitamin d)
- carvedilol
- dexamethasone
- exemestane
- Faslodex (fulvestrant)
- ferrous sulfate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- hydrochlorothiazide
- Lenvima (lenvatinib)
- levothyroxine
- lisinopril
- lorazepam
- metformin
- omeprazole
- ondansetron
- oxycodone
- potassium chloride
- prednisone
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Xgeva (denosumab)
- Zofran (ondansetron)
- Zometa (zoledronic acid)
- Zyrtec (cetirizine)
Afinitor alcohol/food interactions
There are 2 alcohol/food interactions with Afinitor (everolimus).
Afinitor disease interactions
There are 8 disease interactions with Afinitor (everolimus) which include:
- liver disease
- vaccination
- renal disease
- hematologic abnormalities
- blood glucose
- cholesterol
- Infections
- wound complication
Report options
QR code containing a link to this page
More about Afinitor (everolimus)
- Afinitor consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (20)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: mTOR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
